Vision Loss News and Research

RSS

Researchers develop new methods to diagnose glaucoma and detect disease progression

Two new research studies demonstrate that imaging technologies can help to diagnose and detect the progression of glaucoma, one of the leading causes of blindness in the U.S.

2 May 2018

Ways to manage diabetes apart from intensifying glucose control

When you have diabetes, there's a lot of emphasis on controlling your blood sugar levels. And just as important, you and the healthcare team caring for you should pay attention to cardiovascular, kidney and visual health.

27 Apr 2018

FDA authorizes marketing of first AI device to detect diabetic retinopathy

The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.

12 Apr 2018

Healthy diet can be key to preventing age-related macular degeneration

There is no permanent cure for age-related macular degeneration, the leading cause of vision loss in adults ages 50 and older affecting about 10 million Americans.

10 Apr 2018

Unexpected finding may play major role in deterring diabetic retinopathy

Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.

6 Apr 2018

Aging immune cells increase risk for macular degeneration

As people age, their immune systems age, too. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk for age-related macular degeneration, a major cause of blindness in the United States.

5 Apr 2018

First-in-human clinical trial of retinal implant to treat dry AMD

Age-related macular degeneration (AMD) affects more than 1.75 million individuals in the United States. Because the population is aging, that number will increase to almost 3 million by 2020. Between 80 and 90 percent of cases in this country are the dry version of the condition, for which no effective treatment exists.

5 Apr 2018

New trial to test stem cell-based retinal implant for dry age-related macular degeneration

Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for use in people with advanced dry age-related macular degeneration.

4 Apr 2018

Researchers find expression of lymphatic markers in proliferative diabetic retinopathy tissues

Proliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.

29 Mar 2018

Immune cells can repopulate in the retina after elimination, mice study shows

Immune cells called microglia can completely repopulate themselves in the retina after being nearly eliminated, according to a new study in mice from scientists at the National Eye Institute.

21 Mar 2018

Robocall increases diabetic retinopathy screening rates among poor minorities

Automated reminder calls may be an effective tool to improve screening for diabetic eye disease among low-income minority patients, especially African Americans, a new study finds. The study results will be presented Monday at ENDO 2018, the Endocrine Society's 100th annual meeting in Chicago, Ill.

20 Mar 2018

Researchers build better AI algorithms to screen patients for diabetic eye disease

The ability of artificial intelligence (AI) to help screen patients for a common diabetic eye disease gains momentum with a new study published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.

14 Mar 2018

Duke scientists pinpoint new therapeutic target for macular degeneration

Duke Researchers have pinpointed a new therapeutic target for macular degeneration, an eye disease that affects over 10 million Americans and is the leading cause of blindness in adults over 60.

6 Mar 2018

Researchers develop gene therapy that treats a form of macular degeneration in canine model

Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model.

6 Mar 2018

New NIH study aims to identify biomarkers of AMD progression

A new clinical study led by the National Eye Institute, part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration.

26 Feb 2018

Research provides new directions in understanding and fighting glaucoma

Two distinctive handfuls of short molecules that regulate gene expression have been found in the eye fluid of patients with two distinct types of vision degenerating glaucoma.

26 Feb 2018

Diabetes patients twice as likely to develop cataract, study finds

People with diabetes are twice as likely to develop cataract as the general population and the relative risk is highest in those aged between 45 and 54, according to a new study published in the journal Eye.

5 Feb 2018

Fight for Sight awards new grants for 13 vital eye research projects

Fight for Sight, the leading eye research charity, has awarded grants totaling over £180,000 for thirteen vital research projects in partnership with nine different organizations.

2 Feb 2018

Targeted interventions can increase screening for diabetic retinopathy, study shows

Targeted interventions can significantly improve screening for diabetic retinopathy, a complication of diabetes and the leading cause of vision loss amongst working-age adults in the Western word, according to a new Cochrane Systematic Review.

31 Jan 2018

Pixium Vision announces successful implantation and activation of PRIMA Bionic Vision System

Pixium Vision (FR0011950641 - PIX), a company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces today the world’s first successful human implantation and activation of PRIMA, its new generation miniaturized wireless photovoltaic sub-retinal implant, in a patient with severe vision loss from atrophic dry Age-related Macular Degeneration (AMD).

27 Jan 2018